Argenta is the only global Contract Research Organisation (CRO) and Contract Development and Manufacturing Organisation (CDMO) focused on animal health, offering end-to-end services for pharmaceutical product development.

Argenta provides comprehensive solutions from drug development to regulatory services and manufacturing, specialising in the production of animal health pharmaceuticals. The company offers preclinical and clinical research, drug delivery technologies, regulatory affairs, and contract manufacturing. Argenta also excels in the development of novel therapies, including monoclonal antibodies and stem cells.

With a commitment to advancing animal health globally, Argenta supports clients at all stages of product development, ensuring quality and regulatory compliance across its GMP-approved facilities.